ArticleDiabetes technology & therapeutics2022

Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial.

Ron Brazg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.